We received news that AB Science has paused its masitinib studies worldwide, including its phase 3 ALS trial. The company’s announcement of this breaking news can be found here.
AB Science Announces a Voluntary Hold in the Clinical Studies of Masitinib

Join the conversation. Please comment below.